[ad_1] (HealthDay)—In what researchers are calling a “breakthrough,” two preliminary trials have found that either of two triple-drug regimens could potentially benefit 90 percent of people with cystic fibrosis. The trials were …
Read More »3-drug therapy might be cystic fibrosis ‘Breakthrough’
